{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:02Z","timestamp":1787024642565,"version":"build-2736575974"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Neurodegenerative disorders (NDs) are progressive morbidities that represent\na serious health issue in the aging world population. There is a contemporary\nupsurge in worldwide interest in the area of traditional remedies and phytomedicines\nare widely accepted by researchers due to their health-promoted effects and fewer\nside effects. Hesperidin, a flavanone glycoside present in the peels of citrus fruits,\npossesses various biological activities including anti-inflammatory and antioxidant actions.\nIn various preclinical studies, hesperidin has provided significant protective actions\nin a variety of brain disorders such as Alzheimer\u2019s disease, epilepsy, Parkinson\u2019s\ndisease, multiple sclerosis, depression, neuropathic pain, etc. as well as their underlying\nmechanisms. The findings indicate that the neuroprotective effects of hesperidin\nare mediated by modulating antioxidant defence activities and neural growth factors,\ndiminishing apoptotic and neuro-inflammatory pathways. This review focuses on\nthe potential role of hesperidin in managing and treating diverse brain disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1566524023666230320144722","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T07:42:57Z","timestamp":1679470977000},"page":"316-326","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neuroprotective Potential of Hesperidin as Therapeutic Agent in\nthe Treatment of Brain Disorders: Preclinical Evidence-based\nReview"],"prefix":"10.2174","volume":"24","author":[{"given":"Keshav","family":"Bansal","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshita","family":"Singh","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Singh","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Mishra","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"Gao H.M.","year":"2008","unstructured":"Gao H.M.; Hong J.S.; Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol  2008,29(8),357-365","journal-title":"Trends Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"Uttara B.","year":"2009","unstructured":"Uttara B.; Singh A.; Zamboni P.; Mahajan R.; Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol  2009,7(1),65-74","journal-title":"Curr Neuropharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-12-802395-2.00021-3","volume":"145","author":"Kovacs G.G.","year":"2018","unstructured":"Kovacs G.G.; Concepts and classification of neurodegenerative diseases. Handb Clin Neurol  2018,145,301-307","journal-title":"Handb Clin Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.neuron.2012.03.004","volume":"73","author":"Zhou J.","year":"2012","unstructured":"Zhou J.; Gennatas E.D.; Kramer J.H.; Miller B.L.; Seeley W.W.; Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron  2012,73(6),1216-1227","journal-title":"Neuron"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"Fu H.","year":"2018","unstructured":"Fu H.; Hardy J.; Duff K.E.; Selective vulnerability in neurodegenerative diseases. Nat Neurosci  2018,21(10),1350-1358","journal-title":"Nat Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.4103\/0028-3886.217979","volume":"65","author":"Das S.K.","year":"2017","unstructured":"Das S.K.; Ray B.K.; Paul N.; Prevalence, burden, and risk factors of migraine: A community-based study from Eastern India. Neurol India  2017,65(6),1280-1288","journal-title":"Neurol India"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s11011-021-00806-4","volume":"36","author":"Mishra A.","year":"2021","unstructured":"Mishra A.; Bandopadhyay R.; Singh P.K.; Mishra P.S.; Sharma N.; Khurana N.; Neuroinflammation in neurological disorders: Pharmacotherapeutic targets from bench to bedside. Metab Brain Dis  2021,36(7),1591-1626","journal-title":"Metab Brain Dis"},{"key":"ref=8","first-page":"1158","volume":"3","author":"Dhingra A.","year":"2018","unstructured":"Dhingra A.; Chopra B.; Bonthagarala B.; Natural anti-inflammatory agents: Recent progress and future perspectives. Ann Pharmacol Pharm  2018,3(5),1158","journal-title":"Ann Pharmacol Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","volume":"96","author":"Havsteen B.H.","year":"2002","unstructured":"Havsteen B.H.; The biochemistry and medical significance of the flavonoids. Pharmacol Ther  2002,96(2-3),67-202","journal-title":"Pharmacol Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2174\/1568026620666200416085330","volume":"20","author":"Maan G.","year":"2020","unstructured":"Maan G.; Sikdar B.; Kumar A.; Shukla R.; Mishra A.; Role of flavonoids in neurodegenerative diseases: Limitations and future perspectives. Curr Top Med Chem  2020,20(13),1169-1194","journal-title":"Curr Top Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/ijms20123056","volume":"20","author":"Maher P.","year":"2019","unstructured":"Maher P.; The potential of flavonoids for the treatment of neurodegenerative diseases. Int J Mol Sci  2019,20(12),3056","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s12272-020-01292-5","volume":"43","author":"Ko Y.H.","year":"2020","unstructured":"Ko Y.H.; Kim S.K.; Lee S.Y.; Jang C.G.; Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Arch Pharm Res  2020,43(11),1128-1143","journal-title":"Arch Pharm Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuroscience.2016.10.010","volume":"339","author":"Mishra A.","year":"2016","unstructured":"Mishra A.; Goel R.K.; Chronic 5-HT3 receptor antagonism ameliorates seizures and associated memory deficit in pentylenetetrazole-kindled mice. Neuroscience  2016,339,319-328","journal-title":"Neuroscience"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/10408398.2014.906382","volume":"57","author":"Li C.","year":"2017","unstructured":"Li C.; Schluesener H.; Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr  2017,57(3),613-631","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/2212798406666140825120623","volume":"6","author":"Suzuki H.","year":"2014","unstructured":"Suzuki H.; Asakawa A.; Kawamura N.; Yagi T.; Inui A.; Hesperidin potentiates ghrelin signaling. Recent Pat Food Nutr Agric  2014,6(1),60-63","journal-title":"Recent Pat Food Nutr Agric"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1535370220903671","volume":"245","author":"Aggarwal V.","year":"2020","unstructured":"Aggarwal V.; Tuli H.S.; Thakral F.; Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements. Exp Biol Med  2020,245(5),486-497","journal-title":"Exp Biol Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","volume":"85","author":"Youdim K.A.","year":"2003","unstructured":"Youdim K.A.; Dobbie M.S.; Kuhnle G.; Proteggente A.R.; Abbott N.J.; Rice-Evans C.; Interaction between flavonoids and the blood-brain barrier: In vitro studies. J Neurochem  2003,85(1),180-192","journal-title":"J Neurochem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ptr.5256","volume":"29","author":"Parhiz H.","year":"2015","unstructured":"Parhiz H.; Roohbakhsh A.; Soltani F.; Rezaee R.; Iranshahi M.; Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother Res  2015,29(3),323-331","journal-title":"Phytother Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lfs.2014.12.030","volume":"124","author":"Roohbakhsh A.","year":"2015","unstructured":"Roohbakhsh A.; Parhiz H.; Soltani F.; Rezaee R.; Iranshahi M.; Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci  2015,124,64-74","journal-title":"Life Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.foodres.2017.12.025","volume":"106","author":"Mesquita E.","year":"2018","unstructured":"Mesquita E.; Monteiro M.; Simultaneous HPLC determination of flavonoids and phenolic acids profile in P\u00eara-Rio orange juice. Food Res Int  2018,106,54-63","journal-title":"Food Res Int"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.phytochem.2007.11.008","volume":"69","author":"Shimoda K.","year":"2008","unstructured":"Shimoda K.; Hamada H.; Hamada H.; Glycosylation of hesperetin by plant cell cultures. Phytochemistry  2008,69(5),1135-1140","journal-title":"Phytochemistry"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.2174\/0929867324666170718104412","volume":"25","author":"Tejada S.","year":"2019","unstructured":"Tejada S.; Pinya S.; Martorell M.; Potential anti-inflammatory effects of hesperidin from the genus citrus. Curr Med Chem  2019,25(37),4929-4945","journal-title":"Curr Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10408398109527321","volume":"15","author":"Ramana K.V.R.","year":"1981","unstructured":"Ramana K.V.R.; Govindarajan V.S.; Ranganna S.; Kefford J.F.; Citrus fruits-Varieties, chemistry, technology, and quality evaluation. Part I: Varieties, production, handling, and storage. CRC Crit Rev Food Sci Nutr  1981,15(4),353-431","journal-title":"CRC Crit Rev Food Sci Nutr"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0014-2999(00)00180-1","volume":"395","author":"Mitsunaga Y.","year":"2000","unstructured":"Mitsunaga Y.; Takanaga H.; Matsuo H.; Effect of bioflavonoids on vincristine transport across blood\u2013brain barrier. Eur J Pharmacol  2000,395(3),193-201","journal-title":"Eur J Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12031-013-9984-9","volume":"50","author":"Lev N.","year":"2013","unstructured":"Lev N.; Barhum Y.; Ben-Zur T.; Melamed E.; Steiner I.; Offen D.; Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity. J Mol Neurosci  2013,50(3),542-550","journal-title":"J Mol Neurosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","volume":"6","author":"Shulman J.M.","year":"2011","unstructured":"Shulman J.M.; De Jager P.L.; Feany M.B.; Parkinson\u2019s disease: Genetics and pathogenesis. Annu Rev Pathol  2011,6(1),193-222","journal-title":"Annu Rev Pathol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.nut.2014.03.024","volume":"30","author":"Antunes M.S.","year":"2014","unstructured":"Antunes M.S.; Goes A.T.R.; Boeira S.P.; Prigol M.; Jesse C.R.; Protective effect of hesperidin in a model of Parkinson\u2019s disease induced by 6-hydroxydopamine in aged mice. Nutrition  2014,30(11-12),1415-1422","journal-title":"Nutrition"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cbi.2017.11.018","volume":"279","author":"Poetini M.R.","year":"2018","unstructured":"Poetini M.R.; Araujo S.M.; Trindade de Paula M.; Hesperidin attenuates iron-induced oxidative damage and dopamine depletion in Drosophila melanogaster model of Parkinson\u2019s disease. Chem Biol Interact  2018,279,177-186","journal-title":"Chem Biol Interact"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"135426","DOI":"10.1016\/j.neulet.2020.135426","volume":"740","author":"Kesh S.","year":"2021","unstructured":"Kesh S.; Kannan R.R.; Sivaji K.; Balakrishnan A.; Hesperidin downregulates kinases lrrk2 and gsk3\u03b2 in a 6-OHDA induced Parkinson\u2019s disease model. Neurosci Lett  2021,740,135426","journal-title":"Neurosci Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","volume":"57","author":"Antunes M.S.","year":"2020","unstructured":"Antunes M.S.; Cattelan Souza L.; Ladd F.V.L.; Hesperidin ameliorates anxiety-depressive-like behavior in 6-ohda model of parkinson\u2019s disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice. Mol Neurobiol  2020,57(7),3027-3041","journal-title":"Mol Neurobiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/102741","volume":"2013","author":"Tamilselvam K.","year":"2013","unstructured":"Tamilselvam K.; Braidy N.; Manivasagam T.; Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson\u2019s disease. Oxid Med Cell Longev  2013,2013,1-11","journal-title":"Oxid Med Cell Longev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","volume":"16","author":"Cummings J.","year":"2021","unstructured":"Cummings J.; New approaches to symptomatic treatments for Alzheimer\u2019s disease. Mol Neurodegener  2021,16(1),2","journal-title":"Mol Neurodegener"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10571-014-0098-x","volume":"34","author":"Wang D.","year":"2014","unstructured":"Wang D.; Liu L.; Zhu X.; Wu W.; Wang Y.; Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimer\u2019s disease. Cell Mol Neurobiol  2014,34(8),1209-1221","journal-title":"Cell Mol Neurobiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11064-015-1525-1","volume":"40","author":"Thenmozhi A.J.","year":"2015","unstructured":"Thenmozhi A.J.; Raja T.R.W.; Janakiraman U.; Manivasagam T.; Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer\u2019s disease in Wistar rats. Neurochem Res  2015,40(4),767-776","journal-title":"Neurochem Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.12.012","volume":"281","author":"Li C.","year":"2015","unstructured":"Li C.; Zug C.; Qu H.; Schluesener H.; Zhang Z.; Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP\/PS1 mice. Behav Brain Res  2015,281,32-42","journal-title":"Behav Brain Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3390\/nu14153125","volume":"14","author":"Lee D.","year":"2022","unstructured":"Lee D.; Kim N.; Jeon S.H.; Hesperidin improves memory function by enhancing neurogenesis in a mouse model of alzheimer\u2019s disease. Nutrients  2022,14(15),3125","journal-title":"Nutrients"},{"key":"ref=37","first-page":"527","volume":"140","author":"Correale J.","year":"2017","unstructured":"Correale J.; Gait\u00e1n M.I.; Ysrraelit M.C.; Fiol M.P.; Progressive multiple sclerosis: From pathogenic mechanisms to treatment. Brain  2017,140(3),527-546","journal-title":"Brain"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40263-017-0466-4","volume":"31","author":"Farzaei M.H.","year":"2017","unstructured":"Farzaei M.H.; Shahpiri Z.; Bahramsoltani R.; nia MM, Najafi F, Rahimi R. Efficacy and tolerability of phytomedicines in multiple sclerosis patients: A review. CNS Drugs  2017,31(10),867-889","journal-title":"CNS Drugs"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11064-015-1571-8","volume":"40","author":"Ciftci O.","year":"2015","unstructured":"Ciftci O.; Ozcan C.; Kamisli O.; Cetin A.; Basak N.; Aytac B.; Hesperidin, a citrus flavonoid, has the ameliorative effects against experimental autoimmune encephalomyelitis (EAE) in a C57BL\/J6 mouse model. Neurochem Res  2015,40(6),1111-1120","journal-title":"Neurochem Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2016.11.009","volume":"302","author":"Haghmorad D.","year":"2017","unstructured":"Haghmorad D.; Mahmoudi M.B.; Salehipour Z.; Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis. J Neuroimmunol  2017,302,23-33","journal-title":"J Neuroimmunol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","volume":"65","author":"Rosas H.D.","year":"2005","unstructured":"Rosas H.D.; Hevelone N.D.; Zaleta A.K.; Greve D.N.; Salat D.H.; Fischl B.; Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology  2005,65(5),745-747","journal-title":"Neurology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbr.2009.08.028","volume":"206","author":"Kumar P.","year":"2010","unstructured":"Kumar P.; Kumar A.; Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington\u2019s like symptoms in rats: Possible role of nitric oxide. Behav Brain Res  2010,206(1),38-46","journal-title":"Behav Brain Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2013.10.057","volume":"720","author":"Kumar A.","year":"2013","unstructured":"Kumar A.; Chaudhary T.; Mishra J.; Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington\u2019s disease like symptoms in rats: Behavioral, biochemical, cellular and histological evidences. Eur J Pharmacol  2013,720(1-3),16-28","journal-title":"Eur J Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1515\/revneuro-2015-0001","volume":"26","author":"Fakhoury M.","year":"2015","unstructured":"Fakhoury M.; Spinal cord injury: Overview of experimental approaches used to restore locomotor activity. Rev Neurosci  2015,26(4),397-405","journal-title":"Rev Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.wneu.2019.08.108","volume":"132","author":"Jorge A.","year":"2019","unstructured":"Jorge A.; Taylor T.; Agarwal N.; Hamilton D.K.; Current agents and related therapeutic targets for inflammation after acute traumatic spinal cord injury. World Neurosurg  2019,132,138-147","journal-title":"World Neurosurg"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"134619","DOI":"10.1016\/j.neulet.2019.134619","volume":"715","author":"Heo S.D.","year":"2020","unstructured":"Heo S.D.; Kim J.; Choi Y.; Ekanayake P.; Ahn M.; Shin T.; Hesperidin improves motor disability in rat spinal cord injury through anti-inflammatory and antioxidant mechanism via Nrf-2\/HO-1 pathway. Neurosci Lett  2020,715,134619","journal-title":"Neurosci Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5137\/1019-5149.JTN.29611-20.2","volume":"30","author":"Yurtal Z.","year":"2020","unstructured":"Yurtal Z.; Altug M.E.; Unsaldi E.; Secinti I.E.; Kucukgul A.; Investigation of neuroprotective and therapeutic effect of hesperidin in experimental spinal cord injury. Turk Neurosurg  2020,30(6),899-906","journal-title":"Turk Neurosurg"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1734-1140(10)70321-2","volume":"62","author":"Gaur V.","year":"2010","unstructured":"Gaur V.; Kumar A.; Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction. Pharmacol Rep  2010,62(4),635-648","journal-title":"Pharmacol Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10072-014-1725-5","volume":"35","author":"Oztanir M.N.","year":"2014","unstructured":"Oztanir M.N.; Ciftci O.; Cetin A.; Aladag M.A.; Hesperidin attenuates oxidative and neuronal damage caused by global cerebral ischemia\/reperfusion in a C57BL\/J6 mouse model. Neurol Sci  2014,35(9),1393-1399","journal-title":"Neurol Sci"},{"key":"ref=50","first-page":"112","volume":"3","author":"Anovadiya A.P.","year":"2012","unstructured":"Anovadiya A.P.; Sanmukhani J.J.; Tripathi C.B.; Epilepsy: Novel therapeutic targets. J Pharmacol Pharmacother  2012,3(2),112-117","journal-title":"J Pharmacol Pharmacother"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/0253-7613.132180","volume":"46","author":"Kumar A.","year":"2014","unstructured":"Kumar A.; Lalitha S.; Mishra J.; Hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in mice: Possible behavioral, biochemical and mitochondrial alterations. Indian J Pharmacol  2014,46(3),309-315","journal-title":"Indian J Pharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yebeh.2013.06.007","volume":"29","author":"Kumar A.","year":"2013","unstructured":"Kumar A.; Lalitha S.; Mishra J.; Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav  2013,29(1),103-111","journal-title":"Epilepsy Behav"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","volume":"32","author":"Costigan M.","year":"2009","unstructured":"Costigan M.; Scholz J.; Woolf C.J.; Neuropathic pain: A maladaptive response of the nervous system to damage. Annu Rev Neurosci  2009,32(1),1-32","journal-title":"Annu Rev Neurosci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/00207454.2019.1567512","volume":"129","author":"Tao J.","year":"2019","unstructured":"Tao J.; Liu L.; Fan Y.; Role of hesperidin in P2X3 receptor-mediated neuropathic pain in the dorsal root ganglia. Int J Neurosci  2019,129(8),784-793","journal-title":"Int J Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10787-017-0326-3","volume":"25","author":"Carballo-Villalobos A.I.","year":"2017","unstructured":"Carballo-Villalobos A.I.; Gonz\u00e1lez-Trujano M.E.; Alvarado-V\u00e1zquez N.; L\u00f3pez-Mu\u00f1oz F.J.; Pro-inflammatory cytokines involvement in the hesperidin antihyperalgesic effects at peripheral and central levels in a neuropathic pain model. Inflammopharmacology  2017,25(2),265-269","journal-title":"Inflammopharmacology"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"120104","DOI":"10.1016\/j.lfs.2021.120104","volume":"287","author":"Semis H.S.","year":"2021","unstructured":"Semis H.S.; Kandemir F.M.; Kaynar O.; Dogan T.; Arikan S.M.; The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats. Life Sci  2021,287,120104","journal-title":"Life Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/13880209.2013.870584","volume":"52","author":"Visnagri A.","year":"2014","unstructured":"Visnagri A.; Kandhare A.D.; Chakravarty S.; Ghosh P.; Bodhankar S.L.; Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm Biol  2014,52(7),814-828","journal-title":"Pharm Biol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11920-019-1117-x","volume":"21","author":"Cuijpers P.","year":"2019","unstructured":"Cuijpers P.; Quero S.; Dowrick C.; Arroll B.; Psychological treatment of depression in primary care: recent developments. Curr Psychiatry Rep  2019,21(12),129","journal-title":"Curr Psychiatry Rep"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.lfs.2018.10.040","volume":"213","author":"Kosari-Nasab M.","year":"2018","unstructured":"Kosari-Nasab M.; Shokouhi G.; Ghorbanihaghjo A.; Abbasi M.M.; Salari A.A.; Hesperidin attenuates depression-related symptoms in mice with mild traumatic brain injury. Life Sci  2018,213,198-205","journal-title":"Life Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fphar.2020.01325","volume":"11","author":"Zhu X.","year":"2020","unstructured":"Zhu X.; Liu H.; Liu Y.; The antidepressant-like effects of hesperidin in streptozotocin-induced diabetic rats by activating Nrf2\/ARE\/Glyoxalase 1 pathway. Front Pharmacol  2020,11,1325","journal-title":"Front Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.ejcn.1601547","volume":"57","author":"Manach C.","year":"2003","unstructured":"Manach C.; Morand C.; Gil-Izquierdo A.; Bouteloup-Demange C.; R\u00e9m\u00e9sy C.; Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr  2003,57(2),235-242","journal-title":"Eur J Clin Nutr"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/antiox10030435","volume":"10","author":"\u00c1vila-G\u00e1lvez M.\u00c1.","year":"2021","unstructured":"\u00c1vila-G\u00e1lvez M.\u00c1.; Gim\u00e9nez-Bastida J.A.; Gonz\u00e1lez-Sarr\u00edas A.; Esp\u00edn J.C.; New insights into the metabolism of the flavanones eriocitrin and hesperidin: A comparative human pharmacokinetic study. Antioxidants  2021,10(3),435","journal-title":"Antioxidants"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jfca.2013.11.004","volume":"33","author":"Khan M.K.","year":"2014","unstructured":"Khan M.K.; Zill-E-Huma, Dangles O. A comprehensive review on flavanones, the major citrus polyphenols. J Food Compos Anal  2014,33(1),85-104","journal-title":"J Food Compos Anal"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2298\/VSP1401060K","volume":"71","year":"2014","unstructured":"Kunti\u0107 V, Brbori\u0107 J, Holclajtner-Antunovi\u0107 I, Uskokovi\u0107-Markovi\u0107 S. Evaluating the bioactive effects of flavonoid hesperidin: A new literature data survey. Vojnosanit Pregl  2014,71(1),60-65","journal-title":"Vojnosanit Pregl"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1211\/jpp.58.3.0012","volume":"58","author":"Dimpfel W.","year":"2010","unstructured":"Dimpfel W.; Different anticonvulsive effects of hesperidin and its aglycone hesperetin on electrical activity in the rat hippocampus in-vitro. J Pharm Pharmacol  2010,58(3),375-379","journal-title":"J Pharm Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1573413718666220314140848","author":"Zhu X.","year":"2022","unstructured":"Zhu X.; Liu H.; Deng Z.; Yan C.; Liu Y.; Yin X.; Hesperidin exerts anxiolytic-like effects in rats with streptozotocin-induced diabetes via PKA\/CREB signaling. Curr Mol Pharmacol  2022,15","journal-title":"Curr Mol Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/1028415X.2016.1144846","volume":"20","author":"Justin Thenmozhi A.","year":"2017","unstructured":"Justin Thenmozhi A.; William Raja T.R.; Manivasagam T.; Janakiraman U.; Essa M.M.; Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer\u2019s disease. Nutr Neurosci  2017,20(6),360-368","journal-title":"Nutr Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11655-020-2724-4","volume":"27","author":"Lee B.","year":"2021","unstructured":"Lee B.; Choi G.M.; Sur B.; Antidepressant-like effects of hesperidin in animal model of post-traumatic stress disorder. Chin J Integr Med  2021,27(1),39-46","journal-title":"Chin J Integr Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e22787","DOI":"10.1002\/jbt.22787","volume":"35","author":"Wang T.","year":"2021","unstructured":"Wang T.; Zheng L.; Zhang W.; Hesperidin alleviates bupivacaine anesthesia\u2010induced neurotoxicity in SH\u2010SY5Y cells by regulating apoptosis and oxidative damage. J Biochem Mol Toxicol  2021,35(7),e22787","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230320144722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214772\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230320144722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T05:23:48Z","timestamp":1711689828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214772\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524023666230320144722","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}